Taro wins final FDA approval for generic seizure drug

Taro has received tentative approval for this abbreviated new drug application (ANDA) in March 2008.

Lamotrigine is a prescription product used for the treatment of seizures and is bioequivalent to GlaxoSmithKline’s Lamictal tablets.